Mauro E; Ongari M; Lazzari C; Lanza F, La citometria a flusso: nozioni generali, in: Edito da Spandrio L, Milanesi B, Le analisi personalizzate nella medicina di laboratorio, Padova, PICCIN, 2013, pp. 41 - 61 [Chapter or essay]
Ladetto M;Lobetti-Bodoni C;Mantoan B;Ceccarelli M;Boccomini C;Genuardi E;Chiappella A;Baldini L;Rossi G;Pulsoni A;Di Raimondo F;Rigacci L;Pinto A;Galimberti S;Bari A;Rota-Scalabrini D;Ferrari A;Zaja F;Gallamini A;Specchia G;Musto P;Rossi FG;Gamba E;Evangelista A;Vitolo U;Fondazione Italiana Linfomi; Zinzani PL; Lanza F;, Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program., «BLOOD», 2013, 122, pp. 3759 - 3766 [Scientific article]
Lanza F; Spedini P; Generali D; M. Tajana; C. Fiamenghi; M. Ongari; Lazzari C; P. Pinotti; Pasini AL; A. Wahlin J; Walewski; A. Hellmann; H. Johnsen, Quality control of the graft in autologous transplantation, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2013, 1 (suppl), pp. 24 - 32 [Scientific article]
Pasini A; Lanza F, Terapia rituximab-bendamustina/mitoxantrone in un caso di leucemia linfatica cronica evoluto in sindrome di Richter, «QUESTIONI DI CLINICA», 2013, 5, pp. 11 - 12 [Scientific article]
De Vita R; Mazzini G; Gaipa G; Lanza F, XXXI National Conference of the Italian Society of Cytometry (GIC) October 8–11, 2013, Lucca, Italy, «CYTOMETRY. PART A», 2013, 83A, pp. 1124 - 1125 [Scientific article]
CAMPIONI, Diana; Bardi MA; CAVAZZINI, Francesco; TAMMISO, Elisa; Pezzolo E; PREGNOLATO, Emma; Volta E; CUNEO, Antonio; LANZA, Francesco, Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders, «ANNALS OF HEMATOLOGY», 2012, 91, pp. 1563 - 1577 [Scientific article]
Hübel K; Fresen MM; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Jaksic O; Koristek Z; Kröger N; Lanza F; Lemoli RM; Mikala G; Selleslag D; Worel N; Mohty M; Duarte RF., European Data on Stem Cell Mobilization with Plerixafor in Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Multiple Myeloma Patients. A Subgroup Analysis of the European Consortium of Stem Cell Mobilization., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1046 - 1050 [Scientific article]
Worel N; Apperley JF; Basak GW; Douglas KW; Gabriel IH; Geraldes C; Hübel K; Jaksic O; Koristek Z; Lanza F; Lemoli R; Mikala G; Selleslag D; Duarte RF; Mohty M., European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization., «TRANSFUSION», 2012, 52, pp. 2395 - 2400 [Scientific article]
Basak G.W.; Wiktor Jedrzejczak W.; Apperley J.F.; Douglas K.W.; Gabriel I.H.; Geraldes C.; Hübel K.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F., Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1003 - 1005 [Scientific article]
LANZA, Francesco; CAMPIONI, Diana; MAURO, Endri; A. Pasini; RIZZO, Roberta, Immunosuppressive properties of mesenchymal stromal cells, in: Advances in Stem Cell Research, Totowa, Humana Press Inc., 2012, pp. 281 - 301 [Chapter or essay]
Preffer F.; Lanza F., Issue highlights -May 2012, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2012, 82B, pp. v - vi [Scientific article]
Malard F.; Kröger N.; Gabriel I.H.; Hübel K.; Apperley J.F.; Basak G.W.; Douglas K.W.; Geraldes C.; Jaksic O.; Koristek Z.; Lanza F.; Lemoli R.M.; Mikala G.; Selleslag D.; Worel N.; Mohty M.; Duarte R.F., Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide., «BONE MARROW TRANSPLANTATION», 2012, 18, pp. 314 - 317 [Scientific article]
Olivieri A.; Marchetti M.; Lemoli R.M; Tarella C.; Iacone A.; Lanza F.; Rambaldi A.; Bosi A., Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo italianoTrapianto di Midollo Osseo., «BONE MARROW TRANSPLANTATION», 2012, 47(3), pp. 342 - 351 [Scientific article]
Chabannon, C; Pamphilon, D; Vermylen, C; Lanza, F; Slaper-Cortenbach, I; Madrigal, A; Apperley, J, Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical is improved when hematopoietic SCT is performed in a Jacie accredited program, «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 15 - 17 [Scientific article]
ZAULI, Giorgio; Celeghini C; MELLONI, Elisabetta; VOLTAN, Rebecca; Ongari M; Tiribelli M; DI IASIO, Maria Grazia; Lanza F; SECCHIERO, Paola, The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status, «HAEMATOLOGICA», 2012, 97, pp. 1722 - 1730 [Scientific article]
